Heerma Peter 4
4 · Travere Therapeutics, Inc. · Filed Oct 30, 2025
Insider Transaction Report
Form 4
Heerma Peter
CHIEF COMMERCIAL OFFICER
Transactions
- Sale
Common Stock
2025-10-28$30.00/sh−2,662$79,860→ 124,662 total
Footnotes (1)
- [F1]This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.